title: KRAS genotypes and outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab.
authors.forename: Kohei
authors.initials: K
authors.lastname: Shitara
authors.forename: Tomoya
authors.initials: T
authors.lastname: Yokota
authors.forename: Kei
authors.initials: K
authors.lastname: Muro
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068818:Cetuximab; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D018450:Disease Progression; D006801:Humans; D009154:Mutation; D011379:Prognosis; D011518:Proto-Oncogene Proteins / Q000235:genetics; D015203:Reproducibility of Results; D016019:Survival Analysis; D016896:Treatment Outcome; D018631:ras Proteins / Q000235:genetics*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D011518:Proto-Oncogene Proteins; D018631:ras Proteins; D000068818:Cetuximab